Total raised
—
Stage
Pre-Funding
Founded
2023
Headcount
4
HQ
Binyamina-Giv'at Ada
Sector
Health Tech & Life Sciences
About
Hemo-ai is developing a solution with real-time alerts for bleeding and sepsis, enhancing patient care and revolutionizing traditional monitoring methods. The company's system provides an automated, wearable, IV blood monitoring system that integrates data aggregation and AI analysis, making it ideal for use in hospitals, ICUs, ambulances, and field hospitals.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Hemo AI's primary focus in terms of technology and application?
- Hemo AI is developing an AI-powered IV blood monitoring medical device that provides real-time alerts for bleeding and sepsis, aiming to enhance patient care.
- When was Hemo AI founded?
- Hemo AI was founded in October 2023.
- Where is Hemo AI's headquarters located?
- Hemo AI's headquarters is located in Binyamina-Giv'at Ada, Israel.
- What is the current employee count for Hemo AI?
- Hemo AI currently has 4 employees.
- What is Hemo AI's current funding stage?
- Hemo AI is currently in the Pre-Funding stage.
- Who are the founders of Hemo AI?
- The founders of Hemo AI are Liron Ben-Bashat Bergman, David Salton, Ron Beloosesky, and Gilad Cohen.
- What medical conditions does Hemo AI's system aim to monitor?
- Hemo AI's system aims to provide real-time alerts for bleeding and sepsis.
- What is the primary sector classification for Hemo AI?
- Hemo AI's primary sector classification is Health Tech & Life Sciences.
- Does Hemo AI hold any patents?
- Yes, Hemo AI holds 1 patent.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life Sciences
Technologies
Artificial IntelligencePlatforms & Interfaces
Target customers
Government & CityDefense, Safety & SecuritySafetyHealthcare & Life Sciences
Business model
B2B
Highlights
1 PatentsVerified
Tags
healthcaredual-usedefenseartificial-intelligencediagnostics